Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
Recruiting now NCT02061436
Run by Minneapolis Heart Institute Foundation · for All ages · All sexes
What this study is about
Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiated registry is to collect information on treatment strategies and outcomes of consecutive patients undergoing CTO PCI among various participating centers. The information collected will be used to determine the frequency of CTO PCI performed at the participating sites and examine the procedural strategies utilized, and the procedural (both immediate and during follow-up) outcomes.
Who can join (things the study team will check)
✅ You may be able to join if…
- Patients undergoing CTO PCI at each of the participating centers.
🚫 You may not be able to join if…
- None
Where this trial is running
- Banner Samaritan Health Center, Phoenix, Arizona, United States
- Little Rock VA Medical Center, Little Rock, Arkansas, United States
- San Diego VAMC and University of California, San Diego, California, United States
- Torrance Memorial Medical Center, Torrance, California, United States
- Medical Center of the Rockies, Loveland, Colorado, United States
- Memorial Hospital, Jacksonville, Florida, United States
- Piedmont Heart Institute, Atlanta, Georgia, United States
- Emory University Hospital- Emory Heart and Vascular Center, Atlanta, Georgia, United States
- Wellstar Health System, Marietta, Georgia, United States
- Northwestern Bluhm Cardiovascular Institute, Chicago, Illinois, United States
- St. Vincent Heart Center, Indianapolis, Indiana, United States
- Tulane University Heart and Vascular Institute, New Orleans, Louisiana, United States
+ 36 more sites.
Who to contact
Emmanouil S Brilakis, MD, PhD · (214) 857-1547 · esbrilakis@gmail.com
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT02061436.
Verify everything on the official ClinicalTrials.gov record. Page updated September 2026.